Publication | Open Access
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
1.5K
Citations
25
References
2011
Year
Vandetanib demonstrated therapeutic efficacy in a phase III trial of patients with advanced MTC (ClinicalTrials.gov NCT00410761).
| Year | Citations | |
|---|---|---|
Page 1
Page 1